{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:38:17Z","timestamp":1792798697258,"version":"4.5.0"},"reference-count":46,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>An escalating pandemic of the novel SARS-CoV-2 virus is impacting global health, and effective antivirals are needed. Umifenovir (Arbidol) is an indole-derivative molecule, licensed in Russia and China for prophylaxis and treatment of influenza and other respiratory viral infections. It has been shown that umifenovir has broad spectrum activity against different viruses. We evaluated the sensitivity of different coronaviruses, including the novel SARS-CoV-2 virus, to umifenovir using in vitro assays. Using a plaque assay, we revealed an antiviral effect of umifenovir against seasonal HCoV-229E and HCoV-OC43 coronaviruses in Vero E6 cells, with estimated 50% effective concentrations (EC50) of 10.0 \u00b1 0.5 \u00b5M and 9.0 \u00b1 0.4 \u00b5M, respectively. Umifenovir at 90 \u00b5M significantly suppressed plaque formation in CMK-AH-1 cells infected with SARS-CoV. Umifenovir also inhibited the replication of SARS-CoV-2 virus, with EC50 values ranging from 15.37 \u00b1 3.6 to 28.0 \u00b1 1.0 \u00b5M. In addition, 21\u201336 \u00b5M of umifenovir significantly suppressed SARS-CoV-2 virus titers (\u22652 log TCID50\/mL) in the first 24 h after infection. Repurposing of antiviral drugs is very helpful in fighting COVID-19. A safe, pan-antiviral drug such as umifenovir could be extremely beneficial in combating the early stages of a viral pandemic.<\/jats:p>","DOI":"10.3390\/v13081665","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T23:19:33Z","timestamp":1629760773000},"page":"1665","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus"],"prefix":"10.3390","volume":"13","author":[{"given":"Irina","family":"Leneva","sequence":"first","affiliation":[{"name":"Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadezhda","family":"Kartashova","sequence":"additional","affiliation":[{"name":"Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem","family":"Poromov","sequence":"additional","affiliation":[{"name":"Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasiia","family":"Gracheva","sequence":"additional","affiliation":[{"name":"Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6417-3301","authenticated-orcid":false,"given":"Ekaterina","family":"Korchevaya","sequence":"additional","affiliation":[{"name":"Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Glubokova","sequence":"additional","affiliation":[{"name":"Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Borisova","sequence":"additional","affiliation":[{"name":"Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Shtro","sequence":"additional","affiliation":[{"name":"Smorodintsev Research Institute of Influenza, 197376 Saint-Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Loginova","sequence":"additional","affiliation":[{"name":"Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Shchukina","sequence":"additional","affiliation":[{"name":"Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravil","family":"Khamitov","sequence":"additional","affiliation":[{"name":"International Biotechnology Center IBC \u201cGENERIUM\u201d, Volginsky Village, Petushinsky District, 601125 Vladimir, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny","family":"Faizuloev","sequence":"additional","affiliation":[{"name":"Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3181\/0903-MR-94","article-title":"Coronavirus diversity, phylogeny and interspecies jumping","volume":"234","author":"Woo","year":"2009","journal-title":"Exp. Biol. Med."},{"key":"ref_2","first-page":"e7423","article-title":"Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update","volume":"12","author":"Pal","year":"2020","journal-title":"Cureus"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/irv.12563","article-title":"Human coronaviruses and other respiratory infections in young adults on a university campus: Prevalence, symptoms, and shedding","volume":"12","author":"Avis","year":"2018","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_4","first-page":"805","article-title":"Coronavirus infections in working adults. Eight-year study with 229 E and OC 43","volume":"105","author":"Hendley","year":"1972","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1128\/CMR.00023-07","article-title":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection","volume":"20","author":"Cheng","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMsr1408795","article-title":"Middle East Respiratory Syndrome","volume":"376","author":"Zumla","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1164\/rccm.202003-0524LE","article-title":"Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection","volume":"201","author":"Chang","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1358\/dof.1992.017.12.193894","article-title":"Arbidol. Antiviral, immunostimulant, interferon inducer","volume":"17","author":"Glushkov","year":"1992","journal-title":"Drug Future"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.antiviral.2008.10.009","article-title":"Characteristics of arbidol-resistant mutants of influenza virus: Implications for the mechanism of anti-influenza action of arbidol","volume":"81","author":"Leneva","year":"2009","journal-title":"Antiviral Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1073\/pnas.1617020114","article-title":"Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol","volume":"114","author":"Kadam","year":"2017","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2174\/092986708784049658","article-title":"Arbidol: A broad-spectrum antiviral compound that blocks viral fusion","volume":"15","author":"Boriskin","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.antiviral.2014.04.006","article-title":"Arbidol as a broad-spectrum antiviral: An update","volume":"107","author":"Blaising","year":"2014","journal-title":"Antiviral Res."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Haviernik, J., \u0160tef\u00e1nik, M., Fojt\u00edkov\u00e1, M., Kali, S., Tordo, N., Rudolf, I., Hub\u00e1lek, Z., Eyer, L., and Ruzek, D. (2018). A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses. Viruses, 10.","DOI":"10.20944\/preprints201802.0134.v1"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1128\/JVI.02077-15","article-title":"The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses","volume":"90","author":"Borisevich","year":"2016","journal-title":"J. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1038\/s41598-018-27224-4","article-title":"The Antiviral Drug Arbidol Inhibits Zika Virus","volume":"8","author":"Fink","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.intimp.2018.09.043","article-title":"The antiviral activity of arbidol hydrochloride against herpes simplex virus type II (HSV-2) in a mouse model of vaginitis","volume":"68","author":"Du","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"105998","DOI":"10.1016\/j.ijantimicag.2020.105998","article-title":"Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking the trimerization of viral spike glycoprotein","volume":"56","author":"Vankadari","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1093\/bioinformatics\/btaa645","article-title":"COVID-19 Docking Server: A meta server for docking small molecules, peptides and antibodies against potential targets of COVID-19","volume":"36","author":"Kong","year":"2020","journal-title":"Bioinformatics."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/CD9.0000000000000014","article-title":"Antiviral Abidol is Associated with the Reduction of In-Hospital Mortality in COVID-19 Patients","volume":"1","author":"Zeng","year":"2021","journal-title":"Cardiol. Discov."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3389\/fpubh.2020.00249","article-title":"Effectiveness of Arbidol for COVID-19 Prevention in Health Professionals","volume":"8","author":"Yang","year":"2020","journal-title":"Front. Public Health"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s11596-020-2203-3","article-title":"Potential of Arbidol for Post-exposure Prophylaxis of COVID-19 Transmission: A Preliminary Report of a Retrospective Cohort Study","volume":"40","author":"Zhang","year":"2020","journal-title":"Curr. Med. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Zhou, J., Zhang, J., Zhou, J., Yi, H., Lin, Z., Liu, Y., Zhu, M., Wang, H., Zhang, W., and Xu, H. (2020). Clinical characteristics of re-positive COVID-19 patients in Huangshi, China: A retrospective cohort study. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0241896"},{"key":"ref_25","unstructured":"National Health Commission, National Administration of Traditional Chinese Medicine (2021). Diagnosis and treatment protocol for COVID-19 patients (Tentative 8th Edition). Infect. Dis. Immun., 1, 17."},{"key":"ref_26","unstructured":"(2021, June 29). Russian Ministry of Health Interim Guidelines for the Prevention, Diagnosis and Treatment of Novel Coronavirus Infection (COVID-19). Available online: https:\/\/xn--80aesfpebagmfblc0a.xn--p1ai\/ai\/doc\/872\/attach\/Bmr_COVID-19_compressed.pdf."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5501\/wjv.v5.i2.85","article-title":"Determination of 50% endpoint titer using a simple formula","volume":"5","author":"Ramakrishnan","year":"2016","journal-title":"World J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00063198-200405000-00009","article-title":"Antiviral chemotherapeutic agents against respiratory viruses","volume":"10","author":"Brooks","year":"2004","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCov) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"101873","DOI":"10.1016\/j.tmaid.2020.101873","article-title":"Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation","volume":"37","author":"Gendrot","year":"2020","journal-title":"Trav. Med. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF02508106","article-title":"Arbidol kinetics and its effect on influenza A virus. replication in MDCK cell culture","volume":"33","author":"Guskova","year":"1999","journal-title":"Pharm. Chem. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/22221751.2021.1888660","article-title":"The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor","volume":"10","author":"Hu","year":"2021","journal-title":"Emerg. Microbes Infect."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"423","DOI":"10.5414\/CP201843","article-title":"Pharmacokinetics of single and. multiple oral doses of arbidol in healthy Chinese volunteers","volume":"51","author":"Sun","year":"2013","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"ref_37","unstructured":"(2021, June 29). Patient Information Leaflet. Arbidol Maximum, Capsule, 200 mg. Available online: https:\/\/grls.rosminzdrav.ru\/Grls_View_v2.aspx?routingGuid=af9f82b5-7363-4123-bb2c-7fbfe8ffb4fb&t=."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Nojomi, M., Yassin, Z., Keyvani, H., Makiani, M.J., Roham, M., Laali, A., Dehghan, N., Navaei, M., and Ranjbar, M. (2020). Effect of Arbidol (Umifenovir) on COVID-19: A randomized controlled trial. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-05698-w"},{"key":"ref_39","unstructured":"(2020, October 19). Efficacy and Safety of Arbidol in Treatment of Patients with COVID-19 Infection: A Randomized Clinical Trial. Available online: https:\/\/www.researchsquare.com\/article\/rs-91430\/v1."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev-virology-031413-085507","article-title":"Thinking outside the triangle: Replication fidelity of the largest RNA viruses","volume":"1","author":"Smith","year":"2014","journal-title":"Annu. Rev. Virol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tim.2016.09.001","article-title":"Molecular evolution of human coronavirus genomes","volume":"25","author":"Forni","year":"2017","journal-title":"Trends Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijid.2016.01.001","article-title":"Virus susceptibility and clinical effectiveness of anti-influenza drugs during the 2010\u20132011 influenza season in Russia","volume":"43","author":"Leneva","year":"2016","journal-title":"Int. J. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/jmv.25358","article-title":"Umifenovir Susceptibility Monitoring and Characterization of Influenza Viruses Isolated during ARBITR Clinical Study","volume":"91","author":"Leneva","year":"2019","journal-title":"J. Med. Virol."},{"key":"ref_44","first-page":"32","article-title":"Sensitivity of influenza A\/H5 viruses isolated from wild birds on the territory of Russia to arbidol in the cultured MDCK cells","volume":"6","author":"Fedyakina","year":"2005","journal-title":"Vopr. Virus"},{"key":"ref_45","first-page":"42","article-title":"Study of the effect of antiviral drugs on the reproduction of the respiratory syncytial virus by enzyme immunoassay","volume":"47","author":"Leneva","year":"2002","journal-title":"Vopr. Virusol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00705-007-0974-5","article-title":"Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus in vitro and in vivo","volume":"152","author":"Shi","year":"2007","journal-title":"Arch. Virol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/8\/1665\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:49:31Z","timestamp":1760165371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/8\/1665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,23]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["v13081665"],"URL":"https:\/\/doi.org\/10.3390\/v13081665","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,23]]}}}